title: [Clinical experience of treating infection after total hip arthroplasty].
abstract: OBJECTIVE
  To present the experience in the management of the infected total hip arthroplasty (THA).
  
  
  METHODS
  Forty-three cases (44 hips) of infection after THA were reviewed. Eighteen women and 25 men with a mean age of 54 years (range, 24-81 years) were studied. Follow-up ranged from 5 months to 16 years (mean, 3.2 years). Treatment strategies included: one-stage revision (n = 7), two-stage revision (n = 15), resection arthroplasty (n = 13), debridement and retain prosthesis (n = 5), and others (n = 3).
  
  
  RESULTS
  Forty cases had positive culture result with 59 organisms including 19 staphylococcus epidermidis and 10 staphylococcus aureus. Thirty-six cases had been followed up, and no case had infection recurrence. Twenty-nine cases had postoperative Harris hip score averaged 78.5 (45-98).
  
  
  CONCLUSIONS
  The diagnosis and treatment of infection after hip replacement is very difficult. The violence and antibiotic resistant rate of the organisms is high. Two-stage reconstruction of the infected hip is useful and effective because of higher eradication rate of the infection and good postoperative functional result.
authors.affiliation: Department of Orthopaedic Surgery, General Hospital of People's Liberation Army, Beijing 100853, China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Wang
authors.forename: Li-bo
authors.initials: LB
authors.lastname: Hao
authors.forename: Yong-gang
authors.initials: YG
authors.lastname: Zhou
authors.forename: Jing-dong
authors.initials: JD
authors.lastname: Li
authors.forename: Ji-fang
authors.initials: JF
authors.lastname: Wang
authors.forename: Pei-fu
authors.initials: PF
authors.lastname: Tang
authors.forename: Peng
authors.initials: P
authors.lastname: Huang
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001178:Arthroplasty / Q000379:methods*; D019644:Arthroplasty, Replacement, Hip / Q000379:methods*; D003131:Combined Modality Therapy; D005260:Female; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016459:Prosthesis-Related Infections / Q000628:therapy*; D012189:Retrospective Studies; D013203:Staphylococcal Infections / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents